Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis

Grants

Funding Acknowledgements

J.B., L.D., Hickman, Hutchinson and Vickerman are members of the Editorial board of Addiction. S.H. reports personal fees from Abbvie and Gilead outside the submitted work. A.T. reports grants from NHS National Services Scotland during the conduct of the study. L.M. and L.D. are supported by an Australian National Health and Medical Research Council Research Fellowship. H.H. is supported by a grant from the US NIH. L.D. has received investigator- initiated untied educational grants from Reckitt Benckiser, Indivior and Mundipharma. None of those funders had any role in the design, conduct, analysis, write-up or decision to publish their findings.